Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up

Antonio Maria Fea, Alex Bosone, Teresa Rolle, Beatrice Brogliatti, Federico Maria Grignolo, Antonio Maria Fea, Alex Bosone, Teresa Rolle, Beatrice Brogliatti, Federico Maria Grignolo

Abstract

Objective: This pilot study evaluates the pressure lowering potential of subthreshold micropulse diode laser trabeculoplasty (MDLT) for a clinically meaningful duration in patients with medically uncontrolled open angle glaucoma (OAG).

Design: prospective interventional case series.

Participants: Thirty-two eyes of 20 consecutive patients with uncontrolled OAG (12 bilateral and 8 unilateral).

Methods: Confluent subthreshold laser applications over the inferior 180 degrees of the anterior TM using an 810 nm diode laser in a micropulse operating mode. The intraocular pressure (IOP) was measured at baseline and at 1 hour, 1 day, 1 week, 3, 6, 9, and 12 months post-treatment. Flare was measured with a Kowa FM 500 flare-meter at baseline and at 3 hours, 1 day, 1 week, and 12 months post-treatment. After treatment, the patients were maintained on their pre-treatment drug regimen.

Main outcome measures: Criteria for treatment response were IOP reduction >/=3 mm Hg and IOP </=21 mm Hg within the first week after MDLT. Eyes not complying to the above criteria during the follow-up were considered treatment failure. Mean IOP change and percentage of IOP reduction during the follow-up were calculated.

Results: One eye was analyzed for bilateral patients. A total of 20 eyes were thus included. Four eyes (20%) did not respond to treatment during the first week. One additional eye failed at the 6 month visit. The treatment was successful in 15 eyes (75%) at 12 months. The IOP was significantly lower throughout follow-up (p < 0.01). At 12 months, the mean percentage of IOP reduction in the 15 respondent eyes was 22.1% and 12 eyes (60%) had IOP reduction higher than 20%. During the first two postoperative days, one eye with pigmentary glaucoma experienced a significant increase of flare associated with an IOP spike (34 mm Hg) that was controlled with systemic drugs; afterwards it qualified as a respondent and completed the study. No increase of flare was found in any other patient. No peripheral anterior synechiae formed.

Conclusions: In this case series, MDLT was effective in reducing IOP in 75% of medically insufficiently controlled OAG eyes without significant complications. This justifies randomized clinical studies to compare MDLT with current IOP lowering strategies.

Keywords: diode laser; micropulse; open angle glaucoma; subthreshold; trabeculoplasty.

Figures

Figure 1
Figure 1
Mean intraocular pressure (IOP) at various time points up to 12 months (mean ± SE).
Figure 2
Figure 2
Distribution of the percentage of eyes with intraocular pressure (IOP) reduction from baseline

References

    1. Alvarado JA, Alvarado RG, Yeh RF, et al. A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm’s canal endothelial cells. Br J Ophthalmol. 2005;89:1500–5.
    1. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524–7.
    1. Bradley JMB, Anderssohn AM, Colvis CM, et al. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1β and TNFα. Invest Ophthalmol Vis Sci. 2000;41:422–30.
    1. Brancato R, Carassa R, Trabucchi G, et al. Diode laser compared with argon laser for Trabeculoplasty. Am J Ophthalmol. 1991;112:50–5.
    1. Damji KF, Shah KC, Rock WJ, et al. Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol. 1999;83:718–22.
    1. Feldman RM, Katz LJ, Spaeth GL, et al. Long-term efficacy of repeat argon laser trabeculoplasty. Ophthalmology. 1991;98:1061–5.
    1. [GLTRG] Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-up Study: 7. Results. Am J Ophthalmol. 1995;120:718–31.
    1. Harasimowycz PJ, Papamatheakis DG, Latina M, et al. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol. 2005;139:1110–13.
    1. Hodapp E, Parrish RK, II, Anderson DR. Clinical decisions in glaucoma. St Louis: The CV Mosby; 1993. pp. 84–126.
    1. Ingvoldstad DD, Krishna R, Willoughby L. Micropulse diode laser trabeculoplasty versus argon laser trabeculoplasty in the treatment of open angle glaucoma [abstract] Invest Ophthal Vis Sci. 2005;46:123.
    1. Juzych MS, Chopra V, Bantt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology. 2004;111:1853–9.
    1. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995;60:359–71.
    1. Latina MA, Sibayan SA, Shin DH, et al. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology. 1998;105:2082–8.
    1. Latina MA, de Leon JMS. Selective laser trabeculoplasty. Ophthalmol Clin North Am. 2005;18:409–41.
    1. Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: hypertensive efficacy, anterior chamber inflammation, and postoperative pain. Eye. 2004;18:498–502.
    1. McHugh D, Marshall J, Fytche T, et al. Diode laser trabeculoplasty for primary open-angle glaucoma and ocular hypertension. Br J Ophthalmol. 1990;74:743–7.
    1. Midena. Personal communication. AAO 2005; Chicago, IL: 2005.
    1. Parshley DE, Bradley JMB, Fisk A, et al. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest Ophthalmol Vis Sci. 1996;37:795–804.
    1. Reno JB, Rabban UJ, Shin DH, et al. A retrospective comparison of selective laser trabeculoplasty versus argon laser trabeculoplasty in chronic open angle glaucoma patients [abstract] Invest Ophthal Vis Sci. 1999;40:1429.
    1. Traverso CE, Greenidge KC, Spaeth GL. Formation of peripheral anterior synechiae following argon laser trabeculoplasty. A prospective study to determine relationship to position of laser burns. Arch Ophthalmol. 1984;102:861–3.
    1. Weireb RN, Ruderman J, Juster R, et al. Influence of the number of laser burns administered on the early results of argon laser trabeculoplasty. Am J Ophthalmol. 1983;95:287–92.
    1. Wilensky JT, Weinreb RN. Early and late failures of argon laser trabeculoplasty. Arch Ophthalmol. 1983;101:895–7.
    1. Wise JB, Witter SL. Argon laser therapy for open angle glaucoma: a pilot study. Arch Ophthalmol. 1979;97:319–22.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する